Acelrx Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Acelrx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Acelrx Pharmaceuticals Inc
Rating: 1.80383325
Author: Trendlyne DVM scores

about

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamos...

0.55 0.03 (5.77%)

30.38% Fall from 52W High

148.8K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

26.8 / 100

Technically Neutral

45.3 / 100

No estimates available

Acelrx Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acelrx Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamos...

30.38% Fall from 52W High

SWOT Analysis

Acelrx Pharmaceuticals Inc Live Price Chart